chrX-129791039-G-A
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_018990.4(SASH3):c.400G>A(p.Glu134Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000153 in 1,210,016 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 56 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018990.4 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 102Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- combined immunodeficiency, X-linkedInheritance: XL Classification: STRONG Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 28AN: 112195Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.000154 AC: 28AN: 182335 AF XY: 0.000135 show subpopulations
GnomAD4 exome AF: 0.000143 AC: 157AN: 1097821Hom.: 0 Cov.: 30 AF XY: 0.000140 AC XY: 51AN XY: 363191 show subpopulations
GnomAD4 genome AF: 0.000250 AC: 28AN: 112195Hom.: 0 Cov.: 22 AF XY: 0.000146 AC XY: 5AN XY: 34347 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
The c.400G>A (p.E134K) alteration is located in exon 4 (coding exon 4) of the SASH3 gene. This alteration results from a G to A substitution at nucleotide position 400, causing the glutamic acid (E) at amino acid position 134 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at